JP Morgan Call 245 PGR 21.02.2025/ DE000JT2UU61 /
2024-08-15 10:31:21 AM | Chg.+0.49 | Bid7:53:40 PM | Ask7:53:40 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
1.72EUR | +39.84% | 1.69 Bid Size: 30,000 |
1.73 Ask Size: 30,000 |
Progressive Corporat... | 245.00 USD | 2025-02-21 | Call |
Newsfile Corp
08-12
The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid Tumors
GlobeNewswire
06-25
argenx Highlights Breadth of Autoimmune Pipeline with New Multifocal Motor Neuropathy Data at 2024 P...
GlobeNewswire
06-24
Enlivex Announces the Dosing of the First Patient in a Randomized, Placebo-Controlled Phase I/II Tri...
GlobeNewswire
06-24
4DMT Announces FDA Clearance of IND Application for 4D-175 Genetic Medicine for the Treatment of Geo...
GlobeNewswire
06-24
Entrada Therapeutics Reports Positive Preliminary Data in Healthy Volunteers from Phase 1 ENTR-601-4...
GlobeNewswire
06-13
Dyne Therapeutics Presents New Preclinical Data for its Facioscapulohumeral Muscular Dystrophy Progr...
GlobeNewswire
06-12
Ultragenyx Announces Plans to File for Accelerated Approval of UX111 for the Treatment of Sanfilippo...
GlobeNewswire
06-12
Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japa...